Sonova Holding AGSONVF -0.49%89 ROE % is 19.31% as of Mar. 2026, which is 11% below its 10-year median of 21.60. GuruFocus rates SONVF with a GF Score™ of 89/100 and a GF Value™ of $314.08 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Sonova Holding AG ranks better than 87.98% on this metric.
The historical rank and industry rank for Sonova Holding AG's ROE % or its related term are showing as below:
SONVF'
s ROE % Range Over the Past 10 Years
Min: 16.32 Med: 21.6 Max: 28.01
Current: 16.76
During the past 13 years, Sonova Holding AG's highest ROE % was 28.01%. The lowest was 16.32%. And the median was 21.60%.
SONVF's ROE % is ranked better than 87.98% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 2.42
vs SONVF: 16.76
Sonova Holding AG (OTCPK:SONVF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Sonova Holding AG ROE % Related Terms
Sonova Holding AG ROE % Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sonova Holding AG's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's ROE % distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Sonova Holding AG (SONVF) has a ROE % of 19.31% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sonova Holding AG and its competitors. This is 11% below median its historical median of 21.60. Over the past decade, Sonova Holding AG's ROE % has ranged from 16.32 to 28.01. According to the industry distribution chart, Sonova Holding AG ranks #96 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 12%.
Is Sonova Holding AG's ROE % too high?
Sonova Holding AG's current ROE % of 19.31% is 11% below median its 10-year median of 21.60. Over the past 10 years, this metric has ranged from a low of 16.32 to a high of 28.01. The Medical Devices & Instruments industry median ROE % is 2.42. Sonova Holding AG's value of 19.31% is 697.9% above this industry median. Based on the distribution chart, Sonova Holding AG ranks #96 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sonova Holding AG has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's ROE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #96 out of 799 companies for ROE %. This places Sonova Holding AG in the top 12% of its industry — outperforming the majority of peers. The industry median ROE % is 2.42. Sonova Holding AG's value of 19.31% is 697.9% above this benchmark. Historically, Sonova Holding AG's own ROE % has ranged from 16.32 to 28.01 over the past decade. While the company's 10-year median is 21.60 vs. the industry median of 2.42, Sonova Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.42, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current ROE % of 19.31% is 697.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current ROE % is 19.31%, which is 11% below median its own 10-year median of 21.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (SONVF) is currently considered Modestly Undervalued. The stock's GF Value™ is $314.08, compared to a current price of $243.88 — trading 22.4% below its estimated fair value. The current ROE % is 19.31%, which is 11% below median its 10-year median of 21.60 and 697.9% above the Medical Devices & Instruments industry median of 2.42. Sonova Holding AG's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Sonova Holding AG (SONVF), the current ROE % is 19.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (SONVF) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of $243.88 is trading 22.4% below its estimated GF Value™ of $314.08.
GuruFocus considers Sonova Holding AG to be Modestly Undervalued.
Key valuation signals for SONVF:
ROE %: 19.31% (11% below median its 10-year median of 21.60)
GF Value™: $314.08 vs. price of $243.88 (22.4% below fair value)
Industry Position: 697.9% above the Medical Devices & Instruments median (#96 of 799)
No single metric tells the full story. See the SONVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
89GF Score
Get the complete analysis for SONVF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SONVF has been successfully added to your 
